Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]

Can early stage NSCLC be treated with stereotactic radiation therapy?

Dr David Palma – London Health Sciences Centre, London, Canada

Can early stage NSCLC be treated with stereotactic radiation therapy? ( Dr David Palma – London Health Sciences Centre, London, Canada )

Can SBRT be of use for early, operable non-small cell lung cancer?

Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA

Can SBRT be of use for early, operable non-small cell lung cancer? ( Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA )

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel

What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )

Expert discussion on current experience with monoclonal antibodies in multiple...

Prof Antonio Palumbo and Prof Philippe Moreau

Expert discussion on current experience with monoclonal antibodies in multiple myeloma ( Prof Antonio Palumbo and Prof Philippe Moreau )

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

Roundtable discussion on CLL: Expert insights from the iwCLL congress

Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam

Roundtable discussion on CLL: Expert insights from the iwCLL congress ( Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam )

First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA

First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )

Mantle cell lymphoma current treatment practices

Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby

Mantle cell lymphoma current treatment practices ( Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby )

Examining NSCLC responses to durvalumab monotherapy

Brandon Higgs - MedImmune, Gaithersburg, USA

Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden

ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )

Atezolizumab limits disease progression for metastatic urothelial bladder cancer

Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA

Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )

Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC

Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France

Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )

More from ecancer